Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Amazfit Cheetah Series Falls Short for Serious Runners
Digital Health Amazfit Cheetah Series Falls Short for Serious Runners

Standing at the starting line of a major marathon in 2026 requires more than just physical endurance; it demands a deep reliance on the precise biometric data delivered by high-performance wearable technology. Amazfit, operating under the umbrella of Zepp Health, has spent the last few years

Can AI Make Concierge Medicine Affordable for Everyone?
Digital Health Can AI Make Concierge Medicine Affordable for Everyone?

The End of the Transactional Doctor's Visit The traditional healthcare experience often feels more like navigating a frantic industrial assembly line than receiving a compassionate, personalized medical consultation from a trusted advisor. Patients are frequently funneled through fifteen-minute

Who Really Controls Clinical Decisions in Healthcare?
Infrastructure & Management Who Really Controls Clinical Decisions in Healthcare?

The historical boundary between the practice of medicine and the business of managing a healthcare facility has become increasingly blurred as private equity firms and Management Services Organizations expand their reach into every facet of clinical operations. This evolution has prompted a

CMS Proposes Ban on Third-Party Remote Monitoring Vendors
Digital Health CMS Proposes Ban on Third-Party Remote Monitoring Vendors

The rapid evolution of digital health interventions has reached a critical crossroads as the Centers for Medicare and Medicaid Services unveils a proposal that could dismantle the existing framework of remote patient care across the United States. Hidden within the extensive 1,592-page draft for

Raidium Launches AI-Native Oncology Platform at U.S. Sites
Digital Health Raidium Launches AI-Native Oncology Platform at U.S. Sites

The rapid evolution of oncological care has reached a critical juncture where the sheer volume of diagnostic imaging often outpaces the capacity of human specialists to interpret complex longitudinal data with absolute precision. For years, clinicians relied on manual measurements and subjective

How Will New Legislation Reshape US Healthcare?
Infrastructure & Management How Will New Legislation Reshape US Healthcare?

With the midterm elections rapidly approaching, the United States Congress has significantly accelerated its efforts to pass a sweeping series of healthcare reforms that aim to resolve long-standing systemic inefficiencies and the relentless climb of medical costs. This legislative momentum is a

CMS Proposes Ban on Third-Party Remote Patient Monitoring
Digital Health CMS Proposes Ban on Third-Party Remote Patient Monitoring

The landscape of American healthcare is currently navigating a significant crossroads as the Centers for Medicare and Medicaid Services introduces a transformative proposal within its draft 2027 Physician Fee Schedule. This regulatory pivot aims to fundamentally reshape how digital health services

Why Is the Healthcare Cybersecurity Gap Widening in 2026?
Regulatory & Compliance Why Is the Healthcare Cybersecurity Gap Widening in 2026?

James Maitland brings a sophisticated perspective to the intersection of medical robotics and digital infrastructure, fueled by a lifelong passion for how automated systems can transform patient care. As healthcare systems increasingly rely on interconnected IoT devices and complex software suites,

How Is AI Infrastructure Redefining Precision Oncology?
Digital Health How Is AI Infrastructure Redefining Precision Oncology?

The convergence of high-capacity computing and clinical medicine is currently reshaping the boundaries of oncology, turning static diagnostic procedures into proactive biological assessments. This fundamental shift is exemplified by the strategic alliance between Imagene AI and the Tel Aviv

Economic Barriers Stall Access to Theranostic Cancer Care
Imaging & Diagnostics Economic Barriers Stall Access to Theranostic Cancer Care

Recent breakthroughs in nuclear medicine have reached a critical point where the ability to visualize and neutralize malignant cells with surgical precision is often neutralized by the financial inertia of modern healthcare systems. Research conducted at the University of Queensland indicates that

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later